Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05626452 · ClinicalTrials.gov registry record · NA

PrEP Optimization Among Women to Enhance Retention and Uptake

A NA study of PrEP Uptake, sponsored by University of Chicago.

Recruiting
Registry status
NA
Development phase
680
Enrollment target
1
Study location

NCT05626452 is a NA study of PrEP Uptake that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 680 participants, above the 229-participant average among 3 other PrEP Uptake trials with a reported enrollment target (197% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05626452, a NA study of PrEP Uptake, is actively recruiting participants, sponsored by University of Chicago.

RECRUITING
Registry status
NA
Development phase
680 participants
Enrollment target
1
Study location

Study Summary

Black women experience one of the highest incidences of HIV among all subpopulations in the United States, but pre-exposure prophylaxis (PrEP) use among Black cisgender women is very limited. The investigators will implement four strategies (provider training, patient education, EMR optimization, and PrEP navigation) at 12 community health clinics in the Midwest and South. The investigators predict that PrEP use and other related outcomes will improve for participants after the intervention period.

Conditions Studied

Interventions

  • BEHAVIORAL Provider training
  • BEHAVIORAL PrEP Education
  • OTHER EMR Optimization
  • OTHER PrEP Navigation
  • OTHER Provider Audit and Feedback

Study Locations (1)

Illinois

  • University of Chicago - Chicago

Trial Details

FieldValue
Enrollment Target 680 participants
Start Date 2023-08-10
Est. Completion 2026-06
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT05626452

The ClinicalTrials.gov registry entry for NCT05626452 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 680 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 229-participant average among 3 other PrEP Uptake trials with a reported enrollment target (197% higher). The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with PrEP Uptake appearing as the primary indexed condition, and to 5 interventions - of which Provider training is the first listed.

NCT05626452 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05626452 about?

NCT05626452 is a clinical study titled "PrEP Optimization Among Women to Enhance Retention and Uptake". Black women experience one of the highest incidences of HIV among all subpopulations in the United States, but pre-exposure prophylaxis (PrEP) use among Black cisgender women is very limited. The investigators will implement four strategies (provider training, patient education, EMR optimization, an...

What is the current status of trial NCT05626452?

This trial is currently recruiting. It is a NA study. The enrollment target is 680 participants. The study started on 2023-08-10. Estimated completion is 2026-06.

What conditions does trial NCT05626452 study?

This clinical trial studies the following conditions: PrEP Uptake.

What interventions are being tested in trial NCT05626452?

The interventions under investigation include: Provider training (BEHAVIORAL), PrEP Education (BEHAVIORAL), EMR Optimization (OTHER), PrEP Navigation (OTHER), Provider Audit and Feedback (OTHER).

Who is sponsoring clinical trial NCT05626452?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05626452 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PrEP Uptake

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.